Stock listing
OTC:LOBEF Lobe Sciences Ltd Stock
US listing (OTC) of Lobe Sciences Ltd · home listing CSE:LOBE
Follow Lobe Sciences Ltd into a list and get an email when it puts out news.
Share price · OTC:LOBEF
$0.033 USD -0.002 (-6.5%)
Close on Oct 16, 2026
- Ticker
- OTC:LOBEF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 14, 2026
Lobe Sciences Appoints Annette Grimaldi, Former Head of Life Sciences Investment Banking at BMO Capital Markets, to Board of Directors
Latest deck · Sep 15, 2026
Conference Presentation (September 2026)
Conference · 22 slides
Latest news
Financings
Private placement of common shares
Aug 31, 2026
Closed: C$2.16M raised · C$0.085 a share
Use of proceeds: Working capital, general corporate purposes, and advancing the S-100 drug candidate for sickle cell disease, partly via subsidiary Applied Lipid Technologies
Update Aug 18, 2026 · Closed Aug 20, 2026 · Made bigger Aug 28, 2026 · Closed Aug 31, 2026
Decks
Conference Presentation (September 2026)
Conference · 22 slides · Sep 15, 2026
Lobe Sciences Ltd on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 21 in the last 12 months · 60 in all · newest Oct 14, 2026 · oldest 2023
- Decks
- 1 deck · latest Sep 15, 2026
Where Lobe Sciences Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| CSE:LOBE · Home listing | CSE | Canada | CAD |
| OTC:LOBEF · This page | OTC | United States | USD |
| Cboe Canada:LOBE | Cboe Canada | Canada | CAD |
| Frankfurt:LOBE | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about Lobe Sciences Ltd.